GEP19991646B - Butilation Components of Ether Hydroxy-Toluene-Omega-Pyridil and Their Pharmaceutically Acceptable Salts, Pharmaceutical Compositions Comprising Them and Method for Production of Pharmaceutical Compositions - Google Patents

Butilation Components of Ether Hydroxy-Toluene-Omega-Pyridil and Their Pharmaceutically Acceptable Salts, Pharmaceutical Compositions Comprising Them and Method for Production of Pharmaceutical Compositions

Info

Publication number
GEP19991646B
GEP19991646B GEAP1993848A GEAP1993000848A GEP19991646B GE P19991646 B GEP19991646 B GE P19991646B GE AP1993848 A GEAP1993848 A GE AP1993848A GE AP1993000848 A GEAP1993000848 A GE AP1993000848A GE P19991646 B GEP19991646 B GE P19991646B
Authority
GE
Georgia
Prior art keywords
pharmaceutical compositions
butilation
pyridil
omega
production
Prior art date
Application number
GEAP1993848A
Inventor
M Wuelfroth Petra
P Quack Guenter
Junglas Heinz
Gold Markus R
Josef Strohmeier
Peteri Dezsoe
H Leimner Juergen
Jarglis Panayiotis
Original Assignee
Mers Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mers Co Gmbh & Co filed Critical Mers Co Gmbh & Co
Priority to GEAP1993848A priority Critical patent/GEP19991646B/en
Publication of GEP19991646B publication Critical patent/GEP19991646B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1.Technical Result Production of pharmaceutical compositions comprising butilation compounds of ether hy¬droxytoluene-omega-pyridil which have improved antilipidemic and antiatherosclerosis properties 2. Essence Butilation compound of ether hy¬droxytoluene--omega-pyridil comprises the compounds of the formula: in which m = 1, 3. When m = 1 then  = 6, 9, when m = 3, then  = 5, 11, where  = m + n +1. Antilipidemic and antiatherosclerosis pharma¬ceu¬tical composition in the form of active ingredient comprises the mentioned compound in pharma¬ceutically effective amount and acceptable carrier. 3. Field of Application Organic chemistry, madicine. 3 ind. 7 dep. claims, 5 Tables.
GEAP1993848A 1993-06-08 1993-06-08 Butilation Components of Ether Hydroxy-Toluene-Omega-Pyridil and Their Pharmaceutically Acceptable Salts, Pharmaceutical Compositions Comprising Them and Method for Production of Pharmaceutical Compositions GEP19991646B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GEAP1993848A GEP19991646B (en) 1993-06-08 1993-06-08 Butilation Components of Ether Hydroxy-Toluene-Omega-Pyridil and Their Pharmaceutically Acceptable Salts, Pharmaceutical Compositions Comprising Them and Method for Production of Pharmaceutical Compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAP1993848A GEP19991646B (en) 1993-06-08 1993-06-08 Butilation Components of Ether Hydroxy-Toluene-Omega-Pyridil and Their Pharmaceutically Acceptable Salts, Pharmaceutical Compositions Comprising Them and Method for Production of Pharmaceutical Compositions

Publications (1)

Publication Number Publication Date
GEP19991646B true GEP19991646B (en) 1999-06-14

Family

ID=81926186

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP1993848A GEP19991646B (en) 1993-06-08 1993-06-08 Butilation Components of Ether Hydroxy-Toluene-Omega-Pyridil and Their Pharmaceutically Acceptable Salts, Pharmaceutical Compositions Comprising Them and Method for Production of Pharmaceutical Compositions

Country Status (1)

Country Link
GE (1) GEP19991646B (en)

Similar Documents

Publication Publication Date Title
GEP20002330B (en) Tricyclic Pyrimidin Derivatives Capable of Inhibiting Tyrozine Kinases Epidermic Growth Factor Receptor, Pharmaceutical Composition Containing Them and Methods for Treatment
GEP20002188B (en) (54) Taxoids, Preparation Thereof and Pharmaceutical Compositions Containing Same
IL109496A0 (en) Substituted pyrrolidin-3-yl-alkyl-piperidines and pharmaceutical compositions containing them
GEP19991870B (en) Alkyl Amine Derivatives of Substituted Quinoxaline 2,3-Diones as Glutamate Receptor Antagonists
ES8603870A1 (en) Derivatives of 2,2'-iminobisethanol.
AU5932294A (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
GEP20053421B (en) Substituted Pyrazoles As P38 Kinase Inhibitors, Method for Their Production and Pharmaceutical Compositions Containing Them
MY115339A (en) Compositions containing micronized nebivolol
ATE158504T1 (en) EFFORTABLE MIXTURES CONTAINING IBUPROFEN AND METHODS
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
DE3574256D1 (en) New cephem compounds, process for preparation thereof and pharmaceutical compositions containing them
AU560980B2 (en) New vitro alphatic compounds
AU3583989A (en) New cephem compounds and processes for preparation thereof
UA42733C2 (en) Bis-naphthalimide derivatives and pharmaceutically acceptable acid addition salts thereof, pharmaceutical composition containing them showing cytotoxic activity
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
HUT64318A (en) Process for production benzodpyrane derivativs and pharmaceutical preparations containing these compounds as effective substance
ES8800235A1 (en) Syn-isomer of 7-substituted-3-vinyl-3-cephem compounds, processes for production thereof and pharmaceutical compositions containing them.
CA2256391A1 (en) Anticoagulant peptidyl-arginine aldehyde derivatives
RU94000064A (en) New 2-cyano-3-hydroxypropeneamides, method of preparing thereof, and pharmaceutical compositions containing said compounds
MX9707596A (en) Benzamides for neurodegenerative disorder treatment.
GEP19991646B (en) Butilation Components of Ether Hydroxy-Toluene-Omega-Pyridil and Their Pharmaceutically Acceptable Salts, Pharmaceutical Compositions Comprising Them and Method for Production of Pharmaceutical Compositions
AU655869B2 (en) An amphoteric tricyclic compound
GEP20002212B (en) Clavulanic Acid and Diamino Ether Derivatives, Di-Clavulanate Salt, Method for Its Production and Pharmaceutical Composition on Its Basis
UA66751C2 (en) Benzamides as medicament for treatment of neurodegenerative state, a method for the preparation thereof (variants), pharnaceutical composition for treatment of neurodegenerative states and a method for treatment